Phaserx Inc (PZRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PZRX | KTTA | NCNA | ||
Company | Phaserx Inc | Pasithea Therapeutics Corp | Nucana Plc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.30 | 2.66 | 1.2000 | ||
High | 0.34 | 2.66 | 1.2300 | ||
Low | 0.28 | 2.50 | 1.1801 | ||
Last | 0.28 | 2.58 | 1.2050 | ||
Change | -0.03 | -0.08 | -0.0050 | ||
% Change | -9.68% | -2.96% | -0.41% | ||
Volume | 1,044,200 | 10,100 | 38,600 | ||
20-Day Average Volume | 1,409,005 | 20,175 | 76,290 | ||
Previous Close | 0.31 | 2.66 | 1.2100 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.35 | 2.79 | 1.2620 | ||
20-Day Raw Stochastic | 11.70% | 25.74% | 15.91% | ||
20-Day Relative Strength | 38.90% | 36.85% | 36.82% | ||
Weighted Alpha | -79.17 | -74.26 | -85.31 | ||
Today's Opinion | N/A | 100% Sell | 100% Sell | ||
Previous Opinion | N/A | 100% Sell | 100% Sell | ||
Last Month's Opinion | N/A | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -26.32% since 01/26/18 | -2.96% since 12/17/24 | -5.86% since 12/17/24 | ||
Low | 0.27 on 02/01/18 | 2.37 on 12/19/24 | 1.1700 on 12/23/24 | ||
High | 0.40 on 01/29/18 | 2.81 on 12/20/24 | 1.3100 on 12/18/24 | ||
1-Month | |||||
%Chg | -30.00% since 01/02/18 | -16.73% since 11/22/24 | -2.03% since 11/22/24 | ||
Low | 0.22 on 01/08/18 | 2.37 on 12/19/24 | 1.1700 on 12/23/24 | ||
High | 0.71 on 01/18/18 | 3.19 on 12/02/24 | 1.3900 on 12/09/24 | ||
3-Month | |||||
%Chg | -59.42% since 11/02/17 | -34.86% since 09/24/24 | -63.81% since 09/24/24 | ||
Low | 0.22 on 01/08/18 | 2.37 on 12/19/24 | 1.1700 on 12/23/24 | ||
High | 1.62 on 11/28/17 | 7.50 on 09/26/24 | 3.6600 on 09/26/24 | ||
6-Month | |||||
%Chg | -50.00% since 08/02/17 | -48.06% since 06/24/24 | -59.22% since 06/24/24 | ||
Low | 0.22 on 01/08/18 | 2.37 on 12/19/24 | 1.1700 on 12/23/24 | ||
High | 1.89 on 10/13/17 | 7.50 on 09/26/24 | 10.7900 on 08/19/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,285 | 3,369 | 3,198 | ||
Shares Outstanding, K | 11,690 | 1,266 | 2,643 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -20,140,000 | -15,960,000 | -34,370,000 | ||
Last Quarter Sales | N/A | 0 | 0 | ||
Last Quarter Net Income | N/A | -3,000,000 | -5,870,000 | ||
60-Month Beta | 5.40 | 0.73 | 0.95 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -2.87 on 11/13/24 | -2.28 on 11/25/24 | ||
Latest Earnings Date | 03/26/18 | 11/11/24 | 11/21/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |